美国食品药品监督管理局批准了两种复方药丸，即依非韦伦/齐多夫定/拉米夫定片（Epzicom）和特鲁瓦达（Truvada）；对每日一次核苷类药物商业竞争的评论。
FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
作者信息
James John S
出版信息
AIDS Treat News. 2004 Jul 23(403):6.
PMID:15386855
Abstract
Two combinations of currently available drugs, dosed for once-daily use, were approved by the FDA. We are concerned about too fast a rush to once a day.
摘要
美国食品药品监督管理局（FDA）批准了两种目前可用药物的组合，这些组合按每日一次的剂量服用。我们担心过快地急于采用每日一次的用药方式。
相似文献
1
FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
AIDS Treat News. 2004 Jul 23(403):6.
2
FDA approves two combo brand-name AIDS drugs.
Med Health. 2004 Aug 9;58(31):3-4.
3
New once-a-day pill submitted to FDA. First complete regimen in single tablet.
AIDS Alert. 2006 Aug;21(8):91-2.
4
ddI: FDA approves once-daily dosing. Food and Drug Administration.
AIDS Treat News. 1999 Nov 5(No 330):1.
5
Two drugs in one pill.
Posit Aware. 1997 Nov-Dec;8(6):19.
6
Generic Truvada approved.
AIDS Patient Care STDS. 2009 May;23(5):395.
7
New fixed dose once-a-day combinations. Interview by John S. James.
IAPAC Mon. 2004 Nov;10(11):414-5, 432.
8
FDA notifications. Tentative approval granted for combo antiretroviral drug.
AIDS Alert. 2007 Oct;22(10):117-8.
9
FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert. 2009 Sep;24(9):106-7.
10
US FDA approves Emtriva (FTC).
IAPAC Mon. 2003 Aug;9(8):180.
引用本文的文献
1
Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral Drugs.
Antimicrob Agents Chemother. 2013 Sep;57(9):4554-4558. doi: 10.1128/AAC.00283-13. Epub 2013 Jun 24.
Zotero 插件